Australia - engleză - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - carvedilol, quantity: 25 mg - tablet, film coated - excipient ingredients: polysorbate 80; povidone; macrogol 400; magnesium stearate; hypromellose; colloidal anhydrous silica; crospovidone; sucrose; lactose monohydrate; titanium dioxide - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - engleză - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - carvedilol, quantity: 12.5 mg - tablet, film coated - excipient ingredients: sucrose; colloidal anhydrous silica; crospovidone; magnesium stearate; povidone; polysorbate 80; hypromellose; lactose monohydrate; macrogol 400; titanium dioxide - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - engleză - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - carvedilol, quantity: 3.125 mg - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; colloidal anhydrous silica; povidone; magnesium stearate; lactose monohydrate; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii to iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - engleză - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - carvedilol, quantity: 6.25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; povidone; lactose monohydrate; colloidal anhydrous silica; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii to iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - engleză - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - carvedilol, quantity: 12.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; magnesium stearate; crospovidone; microcrystalline cellulose; povidone; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii to iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - engleză - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - carvedilol, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; microcrystalline cellulose; crospovidone; colloidal anhydrous silica; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii to iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - engleză - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - tadalafil, quantity: 20 mg - tablet - excipient ingredients: sodium lauryl sulfate; croscarmellose sodium; magnesium stearate; lactose monohydrate; hyprolose; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin; iron oxide yellow; iron oxide red - tadalis is indicated in adults for the treatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity. efficacy has been shown in idiopathic pah (ipah) and in pah related to collagen vascular disease.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - avanafil, quantity: 200 mg - tablet, uncoated - excipient ingredients: calcium carbonate; mannitol; hyprolose; fumaric acid; iron oxide yellow; magnesium stearate - treatment of erectile dysfunction in adult males.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - avanafil, quantity: 100 mg - tablet, uncoated - excipient ingredients: magnesium stearate; iron oxide yellow; calcium carbonate; fumaric acid; mannitol; hyprolose - treatment of erectile dysfunction in adult males.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - avanafil, quantity: 50 mg - tablet, uncoated - excipient ingredients: magnesium stearate; mannitol; fumaric acid; calcium carbonate; hyprolose; iron oxide yellow - treatment of erectile dysfunction in adult males.